Medication and suggestion in the treatment of depression

Contemporary Hypnosis

Volumn 22, Issue 2, 2005, Pages 59-66

  Kirsch, Irving ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Antidepressant; Meta analyses; Placebo effect

Indexed keywords

ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; CITALOPRAM; FLUOXETINE; LITHIUM; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AMNESIA; ANOREXIA; BLEEDING; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DOSE RESPONSE; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPNOSIS; INSOMNIA; META ANALYSIS; NAUSEA; PSYCHOTHERAPY; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SUGGESTION; SUICIDE;

EID: 20844444549     PISSN: 09605290     EISSN: None     Source Type: Journal    
DOI: 10.1002/ch.24     Document Type: Review

References (15)

1. Abramson LY, Seligman MEP, Teasdale J (1978) Learned helplessness in humans: critique and reformulation. Journal of Abnormal Psychology 87: 49-74.
2. Doyne EJ, Ossipklein DJ, Bowman ED, Osborn KM, McDougallwilson IB, Neimeyer RA (1987) Running versus weight lifting in the treatment of depression. Journal of Consulting and Clinical Psychology 55(5): 748-54.
3. Healy D (2003) Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics 72(2): 71-9.
4. Hollon SD, DeRubeis RJ, Shelton RC, Weiss B (2002) The emperor's new drugs: effect size and moderation effects. Prevention and Treatment 5(27). Available on the World Wide Web http://www.journals.apa.org/prevention/volume5/ pre0050027c.html
5. Hollon SD, Shelton RC, Loosen PT (1991) Cognitive therapy and pharmacotherapy for depression. Journal of Consulting and Clinical Psychology 59: 88-99.
6. Kirsch I (1985) Response expectancy as a determinant of experience and behavior. American Psychologist 40(11): 1189-202.
7. Kirsch I (1994) Clinical hypnosis as a nondeceptive placebo: empirically derived techniques. American Journal of Clinical Hypnosis 37(2): 95-106.
8. Kirsch I (ed.) (1999) How Expectancies Shape Experience. Washington, DC: American Psychological Association.
9. Kirsch I, Montgomery G, Sapirstein G (1995) Hypnosis as an adjunct to cognitive-behavioral psychotherapy - a meta-analysis. Journal of Consulting and Clinical Psychology 63(2): 214-20.
10. Kirsch I, Moore TJ, Scoboria A, Nicholls SS (2002) The emperor's new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. Prevention and Treatment 5. Available on the World Wide Web http://www.journals.apa.org/prevention/ volume5/pre0050023a.html
11. Kirsch I, Sapirstein G (1998) Listening to Prozac but hearing placebo: a meta-analysis of antide-pressant medication. Prevention and Treatment 1, article 0002a. Available on the World Wide Web http.//www.journals.apa.org/prevention/ volume1/pre0010002a.html
12. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine -selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. British Medical Journal 326: 1171-3.
13. Moerman DE (2002) 'The loaves and the fishes': a comment on 'The emperor's new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration'. Prevention and Treatment 5, article 29. Available on the World Wide Web http://www.journals.apa.org/prevention/volume5/ pre0050029c.html
14. Rabkin JG, Markowitz JS, Stewart JW, McGrath PJ, Harrison W, Quitkin FM, Klein DF (1986) How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry Research 19: 75-86.
15. Teasdale JD (1985) Psychological treatments for depression: how do they work? Behaviour Research and Therapy 23: 157-65.